> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Ban on Phenylephrine in Nasal Decongestants
- URL: https://www.fdaweb.com/fda-ban-on-phenylephrine-in-nasal-decongestants/
- Published: 2024-11-07T12:00:00.000Z
- Updated: 2026-09-14T14:46:27.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5158140

*Federal Register* notice: FDA is making available a proposed administrative order entitled “Amending Over-the-Counter Monograph M012: Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use.” If finalized, it would remove orally administered phenylephrine hydrochloride and phenylephrine bitartrate in an effervescent dosage as nasal decongestant active ingredients because they are not effective. To view the notice, click [here](https://public-inspection.federalregister.gov/2024-25910.pdf?ref=fdaweb.com).